Cardiovascular Health GLP-1 agonists are proving to be a valuable tool in the fight against cardiovascular disease, especially for patients with type 2 diabetes who are at a higher risk of heart conditions
Before a court will certify a class action under this rule, plaintiffs must demonstrate that their case satisfies four key threshold criteria: The class must be sufficiently numerous that it would be impractical for the court to handle all lawsuits individually
By stimulating the GLP-1 receptors, these drugs help the body manage blood sugar and hunger more effectively
Supplementary Information 13098_2024_1528_MOESM1_ESM.tif (download TIF Supplementary Material 1
Most protocols follow a gradual dose escalation schedule over 12 weeks before reaching maintenance doses
Y., Caballero, B., Chang, S., Alberg, A